Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 7
2015 5
2016 8
2017 4
2018 5
2019 2
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses.
Del Vecchio NJ, Beaber EF, Garcia MP, Wheeler CM, Kamineni A, Chao C, Chubak J, Corley DA, Owens CL, Winer RL, Pruitt SL, Raine-Bennett T, Feldman S, Silverberg M. Del Vecchio NJ, et al. J Low Genit Tract Dis. 2023 Apr 1;27(2):113-119. doi: 10.1097/LGT.0000000000000721. Epub 2023 Jan 17. J Low Genit Tract Dis. 2023. PMID: 36728078 Free PMC article.
Erratum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353].
Landy R, Mathews C, Robertson M, Wiggins CL, McDonald YJ, Goldberg DW, Scarinci IC, Cuzick J, Sasieni PD, Wheeler CM; New Mexico HPV Pap Registry (NMHPVPR) Steering Committee Members. Landy R, et al. Gynecol Oncol. 2021 Jun;161(3):913. doi: 10.1016/j.ygyno.2021.04.009. Epub 2021 Apr 15. Gynecol Oncol. 2021. PMID: 33867145 Free PMC article. No abstract available.
Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA. Barlow WE, et al. J Natl Cancer Inst. 2020 Mar 1;112(3):238-246. doi: 10.1093/jnci/djz137. J Natl Cancer Inst. 2020. PMID: 31292633 Free PMC article.
Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.
Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K. Doubeni CA, et al. CA Cancer J Clin. 2018 May;68(3):199-216. doi: 10.3322/caac.21452. Epub 2018 Mar 30. CA Cancer J Clin. 2018. PMID: 29603147 Free PMC article.
Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA. Rutter CM, et al. Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29150480 Free PMC article.
33 results